The blood–brain barrier: structure, regulation, and drug delivery

Abbott, N. J. Blood–brain barrier structure and function and the challenges for CNS drug delivery. J. Inherit. Metab. Dis. 36, 437–449 (2013).

Article  CAS  PubMed  Google Scholar 

Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R. & Begley, D. J. Structure and function of the blood–brain barrier. Neurobiol. Dis. 37, 13–25 (2010).

Article  CAS  PubMed  Google Scholar 

Ballabh, P., Braun, A. & Nedergaard, M. The blood–brain barrier: an overview: Structure, regulation, and clinical implications. Neurobiol. Dis. 16, 1–13 (2004).

Article  CAS  PubMed  Google Scholar 

Pandit, R., Chen, L. & Götz, J. The blood-brain barrier: physiology and strategies for drug delivery. Adv. Drug Deliv. Rev. 165-166, 1–14 (2020).

Article  CAS  PubMed  Google Scholar 

Banks, W. A. From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery. Nat. Rev. Drug Discov. 15, 275–292 (2016).

Article  CAS  PubMed  Google Scholar 

Shaw, A. T., Yasothan, U. & Kirkpatrick, P. Crizotinib. Nat. Rev. Drug Discov. 10, 897–898 (2011).

Article  CAS  PubMed  Google Scholar 

Alauddin, M. M., Radaram, B., Rao, Y., Yang, P. & Piwnica-Worms, D. Novel derivatives of anaplastic lymphoma kinase inhibitors: synthesis, radiolabeling and preliminary biological studies on crizotinib and alectinib analogues. Cancer Res. 79, 10–10 (2019).

Article  Google Scholar 

Fromm, M. F. Importance of P-glycoprotein at blood–tissue barriers. Trends Pharmacol. Sci. 25, 423–429 (2004).

Article  CAS  PubMed  Google Scholar 

Endicott, J. A. & Ling, V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58, 137–171 (1989).

Article  CAS  PubMed  Google Scholar 

Choudhari, M. et al. Evolving new-age strategies to transport therapeutics across the blood-brain-barrier. Int. J. Pharm. 599, 120351 (2021).

Article  CAS  PubMed  Google Scholar 

Sweeney, M. D., Sagare, A. P. & Zlokovic, B. V. Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol. 14, 133–150 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arvanitis, C. D., Ferraro, G. B. & Jain, R. K. The blood–brain barrier and blood–tumour barrier in brain tumours and metastases. Nat. Rev. Cancer 20, 26–41 (2020).

Article  CAS  PubMed  Google Scholar 

Tang, W. et al. Emerging blood–brain-barrier-crossing nanotechnology for brain cancer theranostics. Chem. Soc. Rev. 48, 2967–3014 (2019).

Article  CAS  PubMed  Google Scholar 

D’Souza, A., Dave, K. M., Stetler, R. A. & S. Manickam, D. Targeting the blood-brain barrier for the delivery of stroke therapies. Adv. Drug Deliv. Rev. 171, 332–351 (2021).

Article  PubMed  Google Scholar 

Terstappen, G. C., Meyer, A. H., Bell, R. D. & Zhang, W. Strategies for delivering therapeutics across the blood–brain barrier. Nat. Rev. Drug Discov. 20, 362–383 (2021).

Article  CAS  PubMed  Google Scholar 

Zhao, Z., Ukidve, A., Kim, J. & Mitragotri, S. Targeting strategies for tissue-specific drug delivery. Cell 181, 151–167 (2020).

Article  CAS  PubMed  Google Scholar 

Liu, Y., Castro Bravo, K. M. & Liu, J. Targeted liposomal drug delivery: a nanoscience and biophysical perspective. Nanoscale Horiz. 6, 78–94 (2021).

Article  CAS  PubMed  Google Scholar 

Hwang, D., Ramsey, J. D. & Kabanov, A. V. Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. Adv. Drug Deliv. Rev. 156, 80–118 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, H., Chen, Q. & Zhou, S. Carbon-based hybrid nanogels: a synergistic nanoplatform for combined biosensing, bioimaging, and responsive drug delivery. Chem. Soc. Rev. 47, 4198–4232 (2018).

Article  CAS  PubMed  Google Scholar 

Mitchell, M. J. et al. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20, 101–124 (2021).

Article  CAS  PubMed  Google Scholar 

Zou, Y., Huang, B., Cao, L., Deng, Y. & Su, J. Tailored mesoporous inorganic biomaterials: assembly, functionalization, and drug delivery engineering. Adv. Mater. 33, 2005215 (2021).

Article  CAS  Google Scholar 

Wu, F. & Liu, J. Decorated bacteria and the application in drug delivery. Adv. Drug Deliv. Rev. 188, 114443 (2022).

Article  CAS  PubMed  Google Scholar 

Le, Q. V., Lee, J., Lee, H., Shim, G. & Oh, Y. K. Cell membrane-derived vesicles for delivery of therapeutic agents. Acta Pharm. Sin. B 11, 2096–2113 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liang, Y., Duan, L., Lu, J. & Xia, J. Engineering exosomes for targeted drug delivery. Theranostics 11, 3183–3195 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bentivoglio, M. & Kristensson, K. Tryps and trips: cell trafficking across the 100-year-old blood–brain barrier. Trends Neurosci. 37, 325–333 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liebner, S., Czupalla, C. J. & Wolburg, H. Current concepts of blood-brain barrier development. Int. J. Dev. Biol. 55, 467–476 (2011).

Article  CAS  PubMed  Google Scholar 

Upton, D. H. et al. Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy. Theranostics 12, 4734–4752 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harati, R., Villégier, A.-S., Banks, W. A. & Mabondzo, A. Susceptibility of juvenile and adult blood–brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity. J. Neuroinflammation 9, 273 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cai, Z. et al. Role of blood-brain barrier in Alzheimer’s disease. J. Alzheimers Dis. 63, 1223–1234 (2018).

Article  CAS  PubMed  Google Scholar 

Eichler, A. F. et al. The biology of brain metastases-translation to new therapies. Nat. Rev. Clin. Oncol. 8, 344–356 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saraiva, C. et al. Nanoparticle-mediated brain drug delivery: overcoming blood–brain barrier to treat neurodegenerative diseases. J. Control. Release 235, 34–47 (2016).

Article  CAS  PubMed  Google Scholar 

Greene, C. & Campbell, M. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules. Tissue Barriers 4, e1138017 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Ruan, S., Zhou, Y., Jiang, X. & Gao, H. Rethinking CRITID procedure of brain targeting drug delivery: circulation, blood brain barrier recognition, intracellular transport, diseased cell targeting, internalization, and drug release. Adv. Sci. 8, 2004025 (2021).

Article  CAS  Google Scholar 

Zheng, M. et al. Tuning the elasticity of polymersomes for brain tumor targeting. Adv. Sci. 8, e2102001 (2021).

Article  Google Scholar 

Song, Y., Hu, C., Fu, Y. & Gao, H. Modulating the blood–brain tumor barrier for improving drug delivery efficiency and efficacy. VIEW 3, 20200129 (2022).

Article  Google Scholar 

Begley, D. J. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol. Ther. 104, 29–45 (2004).

Article  CAS  PubMed  Google Scholar 

Zhou, Y., Peng, Z., Seven, E. S. & Leblanc, R. M. Crossing the blood-brain barrier with nanoparticles. J. Control. Release 270, 290–303 (2018).

Article  CAS  PubMed  Google Scholar 

Kadry, H., Noorani, B. & Cucullo, L. A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS 17, 69 (2020).

Article  PubMed 

留言 (0)

沒有登入
gif